Pharmacy Board of Australia - Pharmacy Board of Australia sets fee for 2021-22

Pharmacy Board of Australia sets fee for 2021-22

14 Sep 2021

The Pharmacy Board of Australia (the Board) has announced the national registration fee for pharmacy for 2021-22.

The Board has increased the registration fee by indexation to $433.

The fee for practitioners whose principal place of practice is New South Wales is $5071. For more information about the variation in the fee for practitioners whose principal place of practice is NSW, please see the Pharmacy Council of New South Wales website.

A full fee schedule, including the fee arrangements for practitioners whose principal place of practice is NSW, is published on the Board’s website.

The Board’s decision to increase the fee by indexation for the 2021/22 period ensures the Board has sufficient income to allow it to carry out its duties and protect the public.

The Board is committed to keeping the fee as low as possible, while meeting its regulatory obligations to protect the public.

Board Chair Brett Simmonds said that the Board acknowledges that this continues to be a challenging time for health practitioners and sincerely thanks practitioners for their important role in keeping the community safe.

‘We thank the profession for the significant effort in providing frontline services for the public during these very difficult times’ he said.

Ahpra and the Board recognise the effect that the lockdowns may have had on practitioners' practice. The Board has put in place a registration and renewal fee payment plan for any practitioners who are experiencing financial hardship. To read more about the payment plan, see the consideration of financial hardship page.

Practitioner registration fees fund the National Registration and Accreditation Scheme and support the Board’s continuing efforts to support and develop a safe and mobile Australian workforce for registered health practitioners and the public in the most efficient way possible.

Registration fees also allow the Board to facilitate the provision of high-quality education and training for practitioners.

For more information

1NSW is a co-regulatory jurisdiction.


 
 
Page reviewed 14/09/2021